Xenolol-TR 40 Tablet contains Propranolol 40 mg, a non-selective beta-adrenergic receptor blocker used primarily in the management of cardiovascular conditions. Propranolol exerts its therapeutic effects by competitively inhibiting beta-1 and beta-2 adrenergic receptors, leading to decreased heart rate, myocardial contractility, and blood pressure. This results in reduced myocardial oxygen demand and improved cardiac efficiency. Xenolol-TR 40 is indicated for the treatment of hypertension, angina pectoris, cardiac arrhythmias, and prevention of myocardial infarction. Additionally, it is utilized in managing essential tremor, migraine prophylaxis, and certain types of anxiety disorders. The tablet’s extended-release formulation ensures sustained plasma levels, enhancing patient compliance by allowing once-daily dosing. Propranolol is contraindicated in patients with bronchial asthma, severe bradycardia, heart block greater than first degree, and cardiogenic shock. Caution is advised in patients with diabetes mellitus, peripheral vascular disease, and hepatic or renal impairment. Common adverse effects include fatigue, dizziness, bradycardia, and gastrointestinal disturbances. Dose adjustment may be necessary based on clinical response and tolerability. Xenolol-TR 40 should be administered under medical supervision with regular monitoring of cardiovascular parameters to optimize therapeutic outcomes and minimize potential risks.